Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates. (August 2014)
- Record Type:
- Journal Article
- Title:
- Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates. (August 2014)
- Main Title:
- Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates
- Authors:
- Cai, Shuang
Alhowyan, Adel Ali B.
Yang, Qiuhong
Forrest, W. C. Melanie
Shnayder, Yelizaveta
Forrest, M. Laird - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Background</italic>: Hyaluronan (HA) is a ligand for the CD44 receptor which is crucial to cancer cell proliferation and metastasis. High levels of CD44 expression in many cancers have encouraged the development of HA-based carriers for anti-cancer therapeutics.</p> <p> <italic>Purpose</italic>: The objective of this study was to determine whether HA conjugation of anticancer drugs impacts CD44-specific HA-drug uptake and disposition by human head and neck cancer cells.</p> <p> <italic>Methods</italic>: The internalization and cellular disposition of hyaluronan-doxorubicin (HA-DOX), hyaluronan-cisplatin (HA-Pt), and hyaluronan-cyanine7 (HA-Cy7) conjugates were investigated by inhibiting endocytosis pathways, and by inhibiting the CD44-mediated internalization pathways that are known to mediate hyaluronan uptake <italic>in vitro</italic>.</p> <p> <italic>Results</italic>: Cellular internalization of HA was regulated by CD44 receptors. In mouse xenografts, HA conjugation significantly enhanced tumor cell uptake compared to unconjugated drugs.</p> <p> <italic>Discussion</italic>: The results suggested that the main mechanism of HA-based conjugate uptake may be active transport via CD44 in conjunction with a clathrin-dependent endocytic pathway. Other HA receptors, hyaluronan-mediated motility receptor (RHAMM) and lymphatic vessel endothelial hyaluronan receptor (LYVE-1), did not play a significant role in conjugate uptake.</p> <p><abstract> <title>Abstract</title> <p> <italic>Background</italic>: Hyaluronan (HA) is a ligand for the CD44 receptor which is crucial to cancer cell proliferation and metastasis. High levels of CD44 expression in many cancers have encouraged the development of HA-based carriers for anti-cancer therapeutics.</p> <p> <italic>Purpose</italic>: The objective of this study was to determine whether HA conjugation of anticancer drugs impacts CD44-specific HA-drug uptake and disposition by human head and neck cancer cells.</p> <p> <italic>Methods</italic>: The internalization and cellular disposition of hyaluronan-doxorubicin (HA-DOX), hyaluronan-cisplatin (HA-Pt), and hyaluronan-cyanine7 (HA-Cy7) conjugates were investigated by inhibiting endocytosis pathways, and by inhibiting the CD44-mediated internalization pathways that are known to mediate hyaluronan uptake <italic>in vitro</italic>.</p> <p> <italic>Results</italic>: Cellular internalization of HA was regulated by CD44 receptors. In mouse xenografts, HA conjugation significantly enhanced tumor cell uptake compared to unconjugated drugs.</p> <p> <italic>Discussion</italic>: The results suggested that the main mechanism of HA-based conjugate uptake may be active transport via CD44 in conjunction with a clathrin-dependent endocytic pathway. Other HA receptors, hyaluronan-mediated motility receptor (RHAMM) and lymphatic vessel endothelial hyaluronan receptor (LYVE-1), did not play a significant role in conjugate uptake.</p> <p> <italic>Conclusions</italic>: HA conjugation significantly increased CD44-mediated drug uptake and extended the residence time of drugs in tumor cells.</p> </abstract> … (more)
- Is Part Of:
- Journal of drug targeting. Volume 22:Number 7(2014)
- Journal:
- Journal of drug targeting
- Issue:
- Volume 22:Number 7(2014)
- Issue Display:
- Volume 22, Issue 7 (2014)
- Year:
- 2014
- Volume:
- 22
- Issue:
- 7
- Issue Sort Value:
- 2014-0022-0007-0000
- Page Start:
- 648
- Page End:
- 657
- Publication Date:
- 2014-08
- Subjects:
- Drug delivery systems -- Periodicals
Drug Delivery Systems
Vehicles
Drug Administration Routes
Drug Evaluation
615.7 - Journal URLs:
- http://informahealthcare.com/loi/drt ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/1061186X.2014.921924 ↗
- Languages:
- English
- ISSNs:
- 1061-186X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4970.582000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3910.xml